Knee osteoarthritis (OA) is a common and disabling condition. Knee OA affects hundreds of thousands of New Zealanders and costs NZ billions of dollars each year. The impact of OA could be greatly reduced through relatively low-cost but high-value care that can be provided in the community. This care is often not provided due to knee OA being ignored and inaccurate clinician and consumer beliefs about OA. This study will assess the feasibility of a clinical trial exploring the impact on health outcomes when community pharmacists provide novel health information to people with knee OA. This feasibility study will investigate: i) whether people with knee OA can be identified and recruited into a study in community pharmacies; ii) whether novel health information can improve consumer beliefs about OA; and iii) whether it is feasible for community pharmacists to actively explain information to people with knee OA and co-ordinate further support.